Endometriosis 1990. Current Treatment Approaches
Overview
Authors
Affiliations
Endometriosis is an extremely common gynaecological disease, affecting between 1 and 5% of women of reproductive age. Women with endometriosis typically present for medical care with one of more of the following problems: pelvic pain, infertility, or a large adnexal mass (an endometrioma). The primary treatment for an endometrioma is surgical. However, long term postoperative hormone therapy may be necessary to prevent new endometriomas from developing. There is no evidence that hormonal therapy of endometriosis will improve fecundability in women with endometriosis and infertility. Pelvic pain due to endometriosis can be successfully treated with hormonal agents in the majority of patients. Four basic hormonal regimens are currently available for the treatment of endometriosis: (a) danazol; (b) gonadotrophin-releasing hormone (GnRH) [luteinising hormone-releasing hormone (LHRH); gonadorelin] agonists; (c) progesterones (progestins); and (d) combined estrogens and progesterones. Randomised, controlled, clinical trials suggest that danazol and the GnRH agonists are equally effective in the treatment of endometriosis. However, the side effects caused by danazol and the GnRH agonists are markedly different. Danazol produces androgenic side effects including weight gain, hirsutism, acne, oily skin and deepening of the voice. GnRH agonists produce side effects due to hypoestrogenism, including hot flushes, osteoporosis and dry vagina. The ideal drug regimen for the treatment of endometriosis remains to be developed.
Androgen Signaling in Uterine Diseases: New Insights and New Targets.
Lv M, Yu J, Huang Y, Ma J, Xiang J, Wang Y Biomolecules. 2022; 12(11).
PMID: 36358974 PMC: 9687413. DOI: 10.3390/biom12111624.
Toma B, Socolov R, Popa O, Socolov D, Nica I, Agop M J Immunol Res. 2021; 2021:2727174.
PMID: 34957311 PMC: 8695015. DOI: 10.1155/2021/2727174.
Nonsteroidal anti-inflammatory drugs for pain in women with endometriosis.
Brown J, Crawford T, Allen C, Hopewell S, Prentice A Cochrane Database Syst Rev. 2017; 1:CD004753.
PMID: 28114727 PMC: 6464974. DOI: 10.1002/14651858.CD004753.pub4.
Shah D, Correia K, Vitonis A, Missmer S Hum Reprod. 2013; 28(7):1783-92.
PMID: 23674552 PMC: 3685336. DOI: 10.1093/humrep/det120.
Pre and post operative medical therapy for endometriosis surgery.
Yap C, Furness S, Farquhar C Cochrane Database Syst Rev. 2004; (3):CD003678.
PMID: 15266496 PMC: 6984629. DOI: 10.1002/14651858.CD003678.pub2.